News & Insights Press Releases News Resources Webinars Events 2015-03-31 Althea’s New Drug Formulation Technology Gains Attention from Two More Top Pharmaceutical Companies Read more 2014-09-03 Ajinomoto Althea, Inc. Receives European GMP Certification Read more 2014-01-09 Ajinomoto Althea Inc. Now Offering A Novel Protein Production Platform: Corynex® Read more 2014-01-06 Ajinomoto Althea Inc. Appoints J. David Enloe as President and Chief Executive Officer Read more 2013-11-04 Ajinomoto Althea, Inc. Selected as a Finalist in 26th Annual CONNECT Most Innovative New Product Awards Read more 2013-04-04 Ajinomoto Co., Inc. Completes Acquisition of Althea Technologies, Inc Read more 2013-03-06 Ajinomoto Co., Inc. Agrees to Acquire Althea Technologies, Inc. Read more 2013-02-26 Althea Technologies & Profectus Biosciences Sign Manufacturing Agreement for Plasmid DNA Production Read more 2012-10-24 Pfenex Inc. Awards Althea Technologies a Contract for cGMP Manufacturing of Circumsporozoite Protein from Plasmodium falciparum, a Key Malaria Antigen Read more 2012-09-24 Althea Technologies Announces Expanded Roles for Key Executives Read more Genetic Engineering & Biotechnology News CDMOs Forge Links to Next-Gen Antibody Conjugates MJH Life Sciences Manufacturing Materials for Clinical Trials – An Interview MJH Life Sciences Speeding Development and Manufacturing of Materials for Clinical Trials – An Interview Contract Pharma Emphasizing Sustainability in Contract Manufacturing – An Interview Kineticos Life Sciences Panel Discussion – Part III: CDMO Strategy in a COVID-19 World ACS Publications Application of Native Ion Exchange Mass Spectrometry to Intact and Subunit Analysis of Site-Specific Antibody–Drug Conjugates Produced by AJICAP First Generation Technology Fierce Pharma Interview – A CDMO for the Future: Adapting Services for Evolving Needs ACS Publications Good Manufacturing Practice Strategy for Antibody–Drug Conjugate Synthesis Using Site-Specific Chemical Conjugation: First-Generation AJICAP Contract Pharma Contract Pharma’s 20th Anniversary Retrospective Loading…Load More 2025-11-18 Webinar – Engineering the Future of API Manufacturing: A Scientific Approach to Continuous Flow 2024-07-03 Webinar – You Had Me At Flow: The Shift From Batch To Continuous 2024-03-13 Webinar – Breaking Bad Manufacturing Habits: Strategies For Sustainable API Production 2023-11-28 Plasmid Production: The Benefits of Working with an Experienced CDMO 2023-05-09 Strategies for Scaling HPAPI Production Webinar 2022-12-05 Sustainable Approaches to Oligonucleotide Manufacturing 2022-01-10 The Paradigm Shift to Continuous Flow Processes: A Holistic View 2021-05-12 Plasmid Manufacturing for Gene Therapies: An Outsourcing Partnership Duration 2021-01-28 Oligonucleotide Therapeutics: Bridging from Research to Commercial 2020-12-01 Operational Excellence: Crafting a Champion Out of an Athlete 2020-09-22 Webinar: Are You Protecting Your Employees During HPAPI Manufacturing
